Shares in Danish drugmaker Novo Nordisk were 3% higher on Wednesday afternoon after the company presented its first-quarter ...

French drugmaker Ipsen (Euronext: IPN) today announced new data from two late-breaking presentations on Iqirvo (elafibranor) ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

California-based Atara Biotherapeutics (Nasdaq: ATRA) revealed that the US Food and Drug Administration (FDA) has lifted the ...

US biotech Aldeyra Therapeutics is making another attempt to gain marketing approval for its eye drop treatment reproxalap, a ...

The Russian government will consider registering next-in-class drugs based on data from the second phase of clinical trials ...

The US Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign ...

Lossmaking Danish pharma ingredients maker Xellia Pharmaceuticals said it could only survive against Chinese competition by ...

Vertex Pharmaceuticals missed Wall Street estimates for the first quarter of 2025, as sales of its cystic fibrosis (CF) ...

Privately-held Alchemab Therapeutics, a biotech that uses the power of human immune evolution to identify and develop ...

US healthcare giant Johnson & Johnson has presented data from its Phase III LUMEOS study and disclosed that the trial did not ...

US ophthalmics-focused biotech Opus Genetics (Nasdaq: IRD) today revealed that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to ...